Home » Fewer mergers, but higher valuations, during 2011 | M&A Roundup
Welcome: Login | Register

Fewer mergers, but higher valuations, during 2011 | M&A Roundup

January 6, 2012 by MassDevice staff

Merger & acquisition activity slowed last year, but valuations were higher, according to VentureSource; also, Covidien closes Barrx buyout; Henry Schein buys Oak Hill out of animal health division; Mediware, Cumberland Consulting & TriZetto ink buyout deals; Aetna buys iTriage maker Healthagen; and QuadraMed to acquire NCR's health care units.

MassDevice.com M&A Roundup

About 460 companies were bought for $46.4 billion last year, down 13% from 2010, but the deals were valued 30% higher, compared with the $35.6 billion spent in 2010, according to a Dow Jones VentureSource report.

The median price vaulted 77% to $71 million in 2011. Funding rounds were down 12%, to an average of $17 million raised before exit, reflecting lower start-up costs.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

News Well, Health Information Technology, Initial Public Offering (IPO), Mergers & Acquisitions
Permalink
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp